Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon

Journal of Virology

Volumn 88, Issue 23, 2014, Pages 13593-13601

  Wetzel, Jaime L ^a,b   Fensterl, Volker ^a   Sen, Ganes C ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; INTERFERON; INTERFERON LAMBDA3; INTERFERON RECEPTOR; PROTEIN IFIT2; UNCLASSIFIED DRUG; ALPHA BETA INTERFERON RECEPTOR; IFIT2 PROTEIN, MOUSE; IFNAR1 PROTEIN, MOUSE; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; IMMUNOCOMPETENT CELL; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENDAI VIRUS; SENDAI VIRUS INFECTION; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION; WEIGHT REDUCTION; ANIMAL; C57BL MOUSE; DEFICIENCY; FEMALE; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KNOCKOUT MOUSE; LUNG; MALE; METABOLISM; PATHOLOGY; RESPIROVIRUS INFECTION; SURVIVAL ANALYSIS; VIROLOGY;

MUS; SENDAI VIRUS;

ANIMALS; FEMALE; HOST-PATHOGEN INTERACTIONS; INTERFERONS; LUNG; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEINS; RECEPTOR, INTERFERON ALPHA-BETA; RESPIROVIRUS INFECTIONS; SENDAI VIRUS; SURVIVAL ANALYSIS; VIRAL LOAD;

EID: 84911437767     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02201-14     Document Type: Article

References (38)

1. Der SD, Zhou A, Williams BR, Silverman RH. 1998. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 95:15623-15628. http://dx.doi.org/10.1073/pnas.95.26.15623.
2. Schoggins JW, Rice CM. 2011. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 1:519-525. http://dx.doi.org/10.1016/j.coviro.2011.10.008.
3. Durbin RK, Kotenko SV, Durbin JE. 2013. Interferon induction and function at the mucosal surface. Immunol. Rev. 255:25-39. http://dx.doi.org/10.1111/imr.12101.
4. Ivashkiv LB, Donlin LT. 2014. Regulation of type I interferon responses. Nat. Rev. Immunol. 14:36-49. http://dx.doi.org/10.1038/nri3581.
5. Lopez CB, Hermesh T. 2011. Systemic responses during local viral infections: type I IFNs sound the alarm. Curr. Opin. Immunol. 23:495-499. http://dx.doi.org/10.1016/j.coi.2011.06.003.
6. Yount JS, Gitlin L, Moran TM, Lopez CB. 2008. MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai virus defective interfering particles. J. Immunol. 180:4910-4918. http://dx.doi.org/10.4049/jimmunol.180.7.4910.
7. Strahle L, Garcin D, Kolakofsky D. 2006. Sendai virus defectiveinterfering genomes and the activation of interferon-beta. Virology 351: 101-111. http://dx.doi.org/10.1016/j.virol.2006.03.022.
8. Lopez CB, Yount JS, Hermesh T, Moran TM. 2006. Sendai virus infection induces efficient adaptive immunity independently of type I interferons. J. Virol. 80:4538-4545. http://dx.doi.org/10.1128/JVI.80.9.4538-4545 .2006.
9. Chattopadhyay S, Yamashita M, Zhang Y, Sen GC. 2011. The IRF-3/ Bax-mediated apoptotic pathway, activated by viral cytoplasmic RNA and DNA, inhibits virus replication. J. Virol. 85:3708-3716. http://dx.doi.org/10.1128/JVI.02133-10.
10. Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A, Williams BR, Sen GC. 2010. Viral apoptosis is induced by IRF-3- mediated activation of Bax. EMBO J. 29:1762-1773. http://dx.doi.org/10 .1038/emboj.2010.50.
11. Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Wetzel JL, Sen GC. 2013. Inhibition of viral pathogenesis and promotion of the septic shock response to bacterial infection by IRF-3 are regulated by the acetylation and phosphorylation of its coactivators. mBio 4:e00636 -12. http://dx.doi.org/10.1128/mBio.00636-12.
12. Fensterl V, Sen GC. 2011. The ISG56/IFIT1 gene family. J. Interferon Cytokine Res. 31:71-78. http://dx.doi.org/10.1089/jir.2010.0101.
13. Bandyopadhyay SK, Leonard GT, Jr, Bandyopadhyay T, Stark GR, Sen GC. 1995. Transcriptional induction by double-stranded RNA is mediated by interferon-stimulated response elements without activation of interferon- stimulated gene factor 3. J. Biol. Chem. 270:19624-19629. http://dx.doi.org/10.1074/jbc.270.33.19624.
14. Grandvaux N, Servant MJ, ten Oever B, Sen GC, Balachandran S, Barber GN, Lin R, Hiscott J. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:5532-5539. http://dx.doi.org/10 .1128/JVI.76.11.5532-5539.2002.
15. Diamond MS, Farzan M. 2013. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13:46-57. http://dx.doi.org/10.1038/nri3344.
16. Wang C, Pflugheber J, Sumpter R, Jr, Sodora DL, Hui D, Sen GC, Gale M, Jr. 2003. Alpha interferon induces distinct translational control programs to suppress hepatitis C virus RNA replication. J. Virol. 77:3898- 3912. http://dx.doi.org/10.1128/JVI.77.7.3898-3912.2003.
17. Guo J, Hui DJ, Merrick WC, Sen GC. 2000. A new pathway of translational regulation mediated by eukaryotic initiation factor 3. EMBO J. 19: 6891-6899. http://dx.doi.org/10.1093/emboj/19.24.6891.
18. Hui DJ, Terenzi F, Merrick WC, Sen GC. 2005. Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J. Biol. Chem. 280:3433-3440. http://dx.doi.org/10.1074/jbc.M406700200.
19. Terenzi F, Pal S, Sen GC. 2005. Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 340:116-124. http://dx.doi.org/10.1016/j.virol.2005.06.011.
20. Habjan M, Hubel P, Lacerda L, Benda C, Holze C, Eberl CH, Mann A, Kindler E, Gil-Cruz C, Ziebuhr J, Thiel V, Pichlmair A. 2013. Sequestration by IFIT1 impairs translation of 2=O-unmethylated capped RNA. PLoS Pathog. 9:e1003663. http://dx.doi.org/10.1371/journal.ppat.1003663.
21. Kumar P, Sweeney TR, Skabkin MA, Skabkina OV, Hellen CU, Pestova TV. 2014. Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'terminal regions of cap0-, cap1- and 5=ppp-mRNAs. Nucleic Acids Res. 42:3228-3245. http://dx.doi.org/10.1093/nar/gkt1321.
22. Pichlmair A, Lassnig C, Eberle CA, Gorna MW, Baumann CL, Burkard TR, Burckstummer T, Stefanovic A, Krieger S, Bennett KL, Rulicke T, Weber F, Colinge J, Muller M, Superti-Furga G. 2011. IFIT1 is an antiviral protein that recognizes 5'triphosphate RNA. Nat. Immunol. 12:624-630. http://dx.doi.org/10.1038/ni.2048.
23. Daffis S, Szretter KJ, Schriewer J, Li J, Youn S, Errett J, Lin TY, Schneller S, Zust R, Dong H, Thiel V, Sen GC, Fensterl V, Klimstra WB, Pierson TC, Buller RM, Gale M, Jr, Shi PY, Diamond MS. 2010. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468:452-456. http://dx.doi.org/10.1038/nature09489.
24. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8:e1002712. http://dx.doi.org/10.1371/journal.ppat.1002712.
25. Fensterl V, Wetzel JL, Sen GC. 2014. Interferon-induced protein ifit2 protects mice from infection of the peripheral nervous system by vesicular stomatitis virus. J. Virol. 88:10303-10311. http://dx.doi.org/10.1128/JVI .01341-14.
26. Butchi NB, Hinton DR, Stohlman SA, Kapil P, Fensterl V, Sen GC, Bergmann CC. 2014. Ifit2 deficiency results in uncontrolled neurotropic coronavirus replication and enhanced encephalitis via impaired alpha/ beta interferon induction in macrophages. J. Virol. 88:1051-1064. http://dx.doi.org/10.1128/JVI.02272-13.
27. Fensterl V, White CL, Yamashita M, Sen GC. 2008. Novel characteristics of the function and induction of murine p56 family proteins. J. Virol. 82:11045-11053. http://dx.doi.org/10.1128/JVI.01593-08.
28. Sasmono RT, Ehrnsperger A, Cronau SL, Ravasi T, Kandane R, Hickey MJ, Cook AD, Himes SR, Hamilton JA, Hume DA. 2007. Mouse neutrophilic granulocytes express mRNA encoding the macrophage col- ony-stimulating factor receptor (CSF-1R) as well as many other macrophage- specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1. J. Leukoc. Biol. 82:111-123. http://dx.doi.org/10.1189/jlb.1206713.
29. Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. 2008. An important role for type III interferon (IFN-lambda/ IL-28) in TLR-induced antiviral activity. J. Immunol. 180:2474-2485. http://dx.doi.org/10.4049/jimmunol.180.4.2474.
30. Tashiro M, McQueen NL, Seto JT. 1999. Determinants of organ tropism of Sendai virus. Front. Biosci. 4:D642-D645. http://dx.doi.org/10.2741/Tashiro.
31. Irie T, Kiyotani K, Igarashi T, Yoshida A, Sakaguchi T. 2012. Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J. Virol. 86:7136-7145. http://dx.doi.org/10.1128/JVI.06705-11.
32. Strahle L, Marq JB, Brini A, Hausmann S, Kolakofsky D, Garcin D. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins. J. Virol. 81:12227-12237. http://dx.doi.org/10.1128/JVI.01300-07.
33. Chattopadhyay S, Fensterl V, Zhang Y, Veleeparambil M, Yamashita M, Sen GC. 2013. Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. J. Virol. 87:16-24. http://dx.doi.org/10.1128/JVI.01853-12.
34. Peters K, Chattopadhyay S, Sen GC. 2008. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J. Virol. 82:3500-3508. http://dx.doi.org/10.1128/JVI.02536-07.
35. Davidson S, Crotta S, McCabe TM, Wack A. 2014. Pathogenic potential of interferon alphabeta in acute influenza infection. Nat. Commun. 5:3864. http://dx.doi.org/10.1038/ncomms4864.
36. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-211. http://dx.doi.org/10.1126/science.1235214.
37. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207. http://dx.doi.org/10.1126/science.1235208.
38. Mayer-Barber KD, Andrade BB, Oland SD, Amaral EP, Barber DL, Gonzales J, Derrick SC, Shi R, Kumar NP, Wei W, Yuan X, Zhang G, Cai Y, Babu S, Catalfamo M, Salazar AM, Via LE, Barry CE, III, Sher A. 2014. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk. Nature 511:99-103. http://dx.doi.org/10.1038/nature13489.